Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 8/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.36 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.36 |
| ▸ | F2 | P00734 | 3/20 | 0.36 |
| ▸ | TMPRSS6 | Q8IU80 | 3/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | BACE1 | P56817 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7414962 | 0.91 | BCL2 (0.44) | BCL2MCL1 | |
| Trifluoroacetic Acid SCHEMBL7420494 | 0.90 | POLB (0.45) | BCL2MCL1POLBITGB3ITGA2B | |
| SCHEMBL7416087 | 0.89 | POLB (0.37) | MAPTPOLBITGB3ITGA2BF2 | |
| SCHEMBL7414953 | 0.88 | ITGB3 (0.43) | KMT2AITGB3ITGA2BF2TMPRSS6 | |
| SCHEMBL7411794 | 0.88 | POLB (0.48) | BCL2ALDH1A1MCL1POLBITGB3 | |
| SCHEMBL7418351 | 0.88 | TYMS (0.37) | MAPTITGB3ITGA2B | |
| SCHEMBL7412096 | 0.87 | MEN1 (0.43) | ALDH1A1MEN1KMT2AITGB3ITGA2B | |
| SCHEMBL7416574 | 0.87 | ITGB3 (0.45) | ITGB3ITGA2BF2TMPRSS6 | |
| SCHEMBL7415235 | 0.86 | KCNA5 (0.44) | SMN1; SMN2ITGB3ITGA2BF2TMPRSS6 | |
| SCHEMBL7415041 | 0.86 | AR (0.38) | BCL2MCL1MEN1LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6344484-B1 | TREATMENT OF TUMOR GROWTH, METASTASIS, OSTEOPOROSIS, RESTENOSIS, INFLAMMATION, MACULAR DEGENERATION, DIABETIC RETINOPATHY, AND RHEUMATOID ARTHRITIS | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2002-02-05 | — | — | US | disclosed |
| EP-1159262-A1 | TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2001-12-05 | — | — | EP | disclosed |
| WO-2000047552-A1 | TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2000-08-17 | — | — | WO | disclosed |